# Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

> **NCT01667289** · PHASE2 · TERMINATED · sponsor: **Fudan University** · enrollment: 4 (actual)

## Conditions studied

- Extranodal NK/T-cell Lymphoma, Nasal Type

## Interventions

- **RADIATION:** Radiotherapy alone
- **DRUG:** Concurrent chemoradiation

## Key facts

- **NCT ID:** NCT01667289
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2015-06
- **Final completion:** 2017-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** unexpected high grade of mucositis observed
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667289, "Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01667289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*